Table:
begin	end	state
1	25	cytoplasmic
26	43	transmembrane
44	56	non-cytoplasmic
57	77	transmembrane
78	82	cytoplasmic
83	102	transmembrane
103	107	non-cytoplasmic
108	129	transmembrane
130	135	cytoplasmic
136	157	transmembrane
158	187	non-cytoplasmic
188	206	transmembrane
207	225	cytoplasmic
226	245	transmembrane
246	250	non-cytoplasmic
251	268	transmembrane
269	297	cytoplasmic
298	319	transmembrane
320	335	non-cytoplasmic
336	351	transmembrane
352	352	non-cytoplasmic
353	353	cytoplasmic
354	378	transmembrane
379	383	cytoplasmic
384	392	transmembrane
393	403	cytoplasmic

Input:
>AZOBR_RS31250 FitnessBrowser__azobra:AZOBR_RS31250
MSAELNLPARGPRVSMGRFVKAHMREYGMLLSLVAIVLFFQYMTDGTLLQPLNLTNLVLQ
NSYIVIMALGMLLVIVAGHIDLSVGSVVALIGALAATLMVRLHLDFVTTTLLCLLAGAAI
GAVQGFWVAYLRIPSFIVTLAGMLVFRGLCLILLAGQSVGPFPVEFQRLSSGFIPDFLAL
DALNLGKFHLTSLLLCAAVAAAMVAMNTRARLRRQSVAIEQEPLPLFVAKNVALAAVLIY
VGQLMASYRGLPNVLIIMSVLIALYSFVTRNTTVGRRVYALGGNEKAAKLSGIDTRRLSF
YTFVNMGVLAALAGLIFAARLNTATPKAGASFELDVIAACFIGGASASGGVGRVTGAVIG
AFIMGVMNNGMSILGIGIDWQQVIKGMVLLAAVTIDVYNKNKA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server